BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:22 PM
 | 
Mar 04, 2009
 |  BC Extra  |  Top Story

Supreme Court rules against preemption

The U.S. Supreme Court ruled 6-3 Wednesday that an FDA-approved label for Phenergan promethazine from Wyeth (NYSE:WYE) did not preempt state tort law in a product liability suit. In Wyeth v. Levine, the majority concluded that it would not be impossible for the company to comply with both federal and state law obligations and that Levine's common-law...

Read the full 277 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >